 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Antigens for immunological assays (EIA, Western Blot, IHA, Line-assays, etc) are prepared from recombinant proteins, infected cell cultures or microorganisms grown in axenic media (bacteria, parasites, etc). they are partially purified and are supplied lyophilized or frozen. They may contain NaN3 or thimerosal. Refer to the Certificate of analysis Sheet for details.
For cells lines and strains used, please request separate list.
| Code | Product Description | Source | Format | Qty |
| MYAG-001 | Mycoplasma gallisepticum Antigen | recombinant | purified | 1mg |
| MYAG-002 | Mycoplasma hominis Surface Antigen p120 | recombinant | purified | 1mg |
| MYAG-003 | Mycoplasma pneumoniae Antigen | Broth base medium | purified | 1ml |
Mycoplasma pneumoniae Antigen
Product Code
- MYAG-003
Agent
- Mycoplasma pneumoniae. Strain FH. NCTC 10119
Culture System
- Broth culture
Presentation
- Harvested organisms are washed and processed in a two step detergent extraction process. Antigen consists of a lysate of organisms enriched for P1 adhesion protein in phosphate solubilising buffer containing 2% n-octylglucopyranoside
Inactivation
- By detergent treatment. Confirmation by attempted growth under original culture conditions
Preservation
- None
Protein Concentration
- mg/ml by Bradford (Biorad) assay using BSA as standard
Storage
- -20 to -80°C. Repeated freezing and thawing should be avoided
